AnalystsEsther HongEsther Hong's Stock Forecasts
AnalystsEsther Hong
Sectors:
Industries:
Analyst Ranking
Bottom 4%
#4681 out of 4870 analysts
Average Return
-42.44%
Win Rate
12%2 out of 17
Risk vs Reward
Poor
Good
Esther Hong's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Karuna Therapeutics IncKRTX | +42.12% | $126.79 | $180.20 | 2022-03-30 - 2023-03-30 | Strong Buy |
Axsome Therapeutics IncAXSM | +27.44% | $48.87 | $62.28 | 2022-10-31 - 2023-10-31 | Strong Buy |
Esther Hong Analyst Color
Get additional color on Esther Hong's coverage of popular stocks
Esther Hong's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Neuphoria Therapeutics IncNEUP | 3 | Strong Buy | $17.00 | N/A | Maintains | 2 years ago |
Cerevel Therapeutics Holdings IncCERE | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 3 years ago |
Atai Life Sciences NvATAI | 2 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 3 years ago |
Acadia Pharmaceuticals IncACAD | 2 | Hold | $17.00 | N/A | Initiates Coverage On | 3 years ago |
Compass Pathways PLCCMPS | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 3 years ago |
Axsome Therapeutics IncAXSM | 2 | Strong Buy | $95.00 | N/A | Initiates Coverage On | 3 years ago |
Karuna Therapeutics IncKRTX | 2 | Strong Buy | $288.00 | N/A | Initiates Coverage On | 3 years ago |
Sage Therapeutics IncSAGE | 2 | Hold | $41.00 | N/A | Initiates Coverage On | 3 years ago |
Spero Therapeutics IncSPRO | 2 | Hold | $2.00 | N/A | Downgrades | 3 years ago |
Athira Pharma IncATHA | 1 | Strong Buy | $33.00 | N/A | Initiates Coverage On | 3 years ago |
Concert Pharmaceuticals IncCNCE | 2 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 4 years ago |
Aprea Therapeutics IncAPRE | 1 | Strong Buy | $740.00 | N/A | Initiates Coverage On | 4 years ago |
Aldeyra Therapeutics IncALDX | 2 | Strong Buy | $32.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.